There is a women’s leadership gap in the U.S., and women in medtech have been working to alleviate that problem. According to a report from the Centers for American Progress, women hold 52% of professional jobs in the U.S., but only 14.6% are CEOs, 8.1% are top earners and 4.6% are Fortune 500 CEOs. More specifically, […]
Siemens Healthineers taps ex-Abbott Vascular prez Nath to lead lab diag biz | Personnel Moves January 30, 2018
Siemens (NYSE:SI) Healthineers said today it tapped former Abbott (NYSE:ABT) Vascular president Dr. Deepak Nath as its new laboratory diagnostics business president, taking over for Franz Walt who operated as president from 2014 to 2017. Nath spent 10 years with Abbott, serving most recently as its vascular division president and as an executive officer of the company, and […]
SureFire Medical names pharma vet Szela as president, CEO | Personnel Moves – Jan. 26, 2018
SureFire Medical has named pharma veteran Mary Szela as its president, CEO and board member, succeeding founder James Chomas, who has served as the company’s chief executive and president since 2009. Chomas will assume the role of chief technology officer and oncology strategy officer, focusing his efforts on the the company’s oncology drug-delivery tech. Get the […]
Surefire Medical touts infusion tech in liver cancer trial
Surefire Medical touted data today from a retrospective analysis of 85 bridge-to-transplant liver cancer patients treated with transarterial chemoembolization. The data showed that therapy delivered using the Surefire infusion system yielded an 80% complete response in 1 treatment compared to 52% with a standard endhole microcatheter. The analysis also demonstrated a lower recurrence rate of […]
Surefire Medical raises $15m in Series C
Direct-to-tumor delivery system developer Surefire Medical said yesterday it brought in $15 million in a Series C round to support the global launch of its Surefire Precision device designed to treat primary liver cancer. The round was led by Tullis Health Investors, and joined by KMG Capital Partners, Partisan Management Group, MCG partners, High Country […]
Surefire Medical lands $18M Series B round
Surefire Medical said it brought in $18.2 million in a Series B funding round it plans to use to further development of its infusion device for liver cancer.
The Westminster, Colo.-based medical device company said new backer Super Angel investors joined existing investors MCG Partners, Partisan Management Group and High Country Ventures in the round.
FDA clears Surefire’s angiographic catheters
Colorado- based medical device company Surefire won FDA clearance for its suite of angiographic catheters, which have different curve styles to help interventional radiologists access patient anatomies during infusion procedures.
